Les Laboratoires Servier SAS - Product Pipeline Review - 2016

  • ID: 3693098
  • Company Profile
  • 60 pages
  • Global Markets Direct
  • Laboratoires Servier
1 of 4
Les Laboratoires Servier SAS - Product Pipeline Review - 2016

Summary

‘Les Laboratoires Servier SAS - Product Pipeline Review - 2016’, provides an overview of the Les Laboratoires Servier SAS’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Les Laboratoires Servier SAS, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Our report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the pipeline therapeutic landscape of Les Laboratoires Servier SAS
- The report provides overview of Les Laboratoires Servier SAS including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report assesses Les Laboratoires Servier SAS’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report features Les Laboratoires Servier SAS’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

- Evaluate Les Laboratoires Servier SAS’s strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Les Laboratoires Servier SAS
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Les Laboratoires Servier SAS’s pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
READ MORE
Note: Product cover images may vary from those shown
2 of 4
List of Tables

List of Figures

Les Laboratoires Servier SAS Snapshot

Les Laboratoires Servier SAS Overview

Key Information

Key Facts

Les Laboratoires Servier SAS - Research and Development Overview

Key Therapeutic Areas

Les Laboratoires Servier SAS - Pipeline Review

Pipeline Products by Stage of Development

Pipeline Products - Monotherapy

Pipeline Products - Combination Treatment Modalities

Pipeline Products - Partnered Products

Partnered Products/Combination Treatment Modalities

Les Laboratoires Servier SAS - Pipeline Products Glance

Les Laboratoires Servier SAS - Late Stage Pipeline Products

Pre-Registration Products/Combination Treatment Modalities

Phase III Products/Combination Treatment Modalities

Les Laboratoires Servier SAS - Clinical Stage Pipeline Products

Phase II Products/Combination Treatment Modalities

Phase I Products/Combination Treatment Modalities

Les Laboratoires Servier SAS - Early Stage Pipeline Products

Preclinical Products/Combination Treatment Modalities

Discovery Products/Combination Treatment Modalities

Les Laboratoires Servier SAS - Drug Profiles

(amlodipine besylate + perindopril)

Product Description

Mechanism of Action

R&D Progress

ivabradine hydrochloride

Product Description

Mechanism of Action

R&D Progress

(amlodipine besylate + indapamide + perindopril)

Product Description

Mechanism of Action

R&D Progress

(atorvastatin calcium + perindopril)

Product Description

Mechanism of Action

R&D Progress

(indapamide + perindopril)

Product Description

Mechanism of Action

R&D Progress

lucitanib

Product Description

Mechanism of Action

R&D Progress

S-38093

Product Description

Mechanism of Action

R&D Progress

S-38844

Product Description

Mechanism of Action

R&D Progress

S-47445

Product Description

Mechanism of Action

R&D Progress

S-49076

Product Description

Mechanism of Action

R&D Progress

NMSP-153

Product Description

Mechanism of Action

R&D Progress

S-055746

Product Description

Mechanism of Action

R&D Progress

Small Molecule to Inhibit Mcl-1 for Cancer

Product Description

Mechanism of Action

R&D Progress

Drugs to Inhibit Insulin-Regulated AminoPeptidase for Alzheimer’s Disease

Product Description

Mechanism of Action

R&D Progress

Monoclonal Antibodies for Cancer

Product Description

Mechanism of Action

R&D Progress

Drugs for Triple Negative Breast Cancer

Product Description

Mechanism of Action

R&D Progress

Small Molecules for Central Nervous System Disorders

Product Description

Mechanism of Action

R&D Progress

Les Laboratoires Servier SAS - Pipeline Analysis

Les Laboratoires Servier SAS - Pipeline Products by Target

Les Laboratoires Servier SAS - Pipeline Products by Route of Administration

Les Laboratoires Servier SAS - Pipeline Products by Molecule Type

Les Laboratoires Servier SAS - Pipeline Products by Mechanism of Action

Les Laboratoires Servier SAS - Recent Pipeline Updates

Les Laboratoires Servier SAS - Dormant Projects

Les Laboratoires Servier SAS - Discontinued Pipeline Products

Discontinued Pipeline Product Profiles

agomelatine

terutroban

Les Laboratoires Servier SAS - Company Statement

Les Laboratoires Servier SAS - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Appendix

Methodology

Coverage

Secondary Research

Primary Research

Expert Panel Validation

Contact Us

Disclaimer

List of Tables

Les Laboratoires Servier SAS, Key Information

Les Laboratoires Servier SAS, Key Facts

Les Laboratoires Servier SAS - Pipeline by Indication, 2016

Les Laboratoires Servier SAS - Pipeline by Stage of Development, 2016

Les Laboratoires Servier SAS - Monotherapy Products in Pipeline, 2016

Les Laboratoires Servier SAS - Combination Treatment Modalities in Pipeline, 2016

Les Laboratoires Servier SAS - Partnered Products in Pipeline, 2016

Les Laboratoires Servier SAS - Partnered Products/ Combination Treatment Modalities, 2016

Les Laboratoires Servier SAS - Pre-Registration, 2016

Les Laboratoires Servier SAS - Phase III, 2016

Les Laboratoires Servier SAS - Phase II, 2016

Les Laboratoires Servier SAS - Phase I, 2016

Les Laboratoires Servier SAS - Preclinical, 2016

Les Laboratoires Servier SAS - Discovery, 2016

Les Laboratoires Servier SAS - Pipeline by Target, 2016

Les Laboratoires Servier SAS - Pipeline by Route of Administration, 2016

Les Laboratoires Servier SAS - Pipeline by Molecule Type, 2016

Les Laboratoires Servier SAS - Pipeline Products by Mechanism of Action, 2016

Les Laboratoires Servier SAS - Recent Pipeline Updates, 2016

Les Laboratoires Servier SAS - Dormant Developmental Projects,2016

Les Laboratoires Servier SAS - Discontinued Pipeline Products, 2016

Les Laboratoires Servier SAS, Other Locations

Les Laboratoires Servier SAS, Subsidiaries

List of Figures

Les Laboratoires Servier SAS - Pipeline by Top 10 Indication, 2016

Les Laboratoires Servier SAS - Pipeline by Stage of Development, 2016

Les Laboratoires Servier SAS - Monotherapy Products in Pipeline, 2016

Les Laboratoires Servier SAS - Combination Treatment Modalities in Pipeline, 2016

Les Laboratoires Servier SAS - Partnered Products in Pipeline, 2016

Les Laboratoires Servier SAS - Pipeline by Top 10 Target, 2016

Les Laboratoires Servier SAS - Pipeline by Route of Administration, 2016

Les Laboratoires Servier SAS - Pipeline by Molecule Type, 2016

Les Laboratoires Servier SAS - Pipeline Products by Top 10 Mechanism of Action, 2016
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll